NASDAQ:WVE - Wave Life Sciences News Headlines

$26.76
-0.17 (-0.63 %)
(As of 06/20/2019 03:37 PM ET)
Today's Range
$26.63
Now: $26.76
$27.6150
50-Day Range
$22.49
MA: $25.68
$28.04
52-Week Range
$22.25
Now: $26.76
$56.00
Volume124,272 shs
Average Volume274,736 shs
Market Capitalization$916.80 million
P/E RatioN/A
Dividend YieldN/A
Beta0.75

Headlines

Wave Life Sciences (NASDAQ WVE) News Headlines

Source:
DateHeadline
Wave Life Sciences to Present at Parent Project Muscular Dystrophy 2019 Annual ConferenceWave Life Sciences to Present at Parent Project Muscular Dystrophy 2019 Annual Conference
finance.yahoo.com - June 12 at 2:11 PM
Wave Life Sciences Ltd (NASDAQ:WVE) Given Average Rating of "Hold" by BrokeragesWave Life Sciences Ltd (NASDAQ:WVE) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - June 11 at 4:35 PM
$15.76 Million in Sales Expected for Wave Life Sciences Ltd (WVE) This Quarter$15.76 Million in Sales Expected for Wave Life Sciences Ltd (WVE) This Quarter
www.americanbankingnews.com - June 2 at 5:45 AM
Wave Life Sciences Ltd (WVE) Expected to Post Earnings of -$1.05 Per ShareWave Life Sciences Ltd (WVE) Expected to Post Earnings of -$1.05 Per Share
www.americanbankingnews.com - May 31 at 2:08 PM
Wave Life Sciences to Present at the Jefferies 2019 Healthcare ConferenceWave Life Sciences to Present at the Jefferies 2019 Healthcare Conference
www.nasdaq.com - May 22 at 4:38 PM
Wave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business UpdateWave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update
www.marketwatch.com - May 10 at 11:20 AM
Wave Life Sciences (WVE) Reports Q1 Loss, Misses Revenue EstimatesWave Life Sciences (WVE) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 10 at 11:20 AM
Is WAVE Life Sciences Ltd. (WVE) A Good Stock To Buy ?Is WAVE Life Sciences Ltd. (WVE) A Good Stock To Buy ?
finance.yahoo.com - May 2 at 4:38 PM
Wave Life Sciences (WVE) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseWave Life Sciences (WVE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - May 1 at 4:37 PM
What Are Analysts Saying About Wave Life Sciences Ltd.'s (NASDAQ:WVE) Earnings Trajectory?What Are Analysts Saying About Wave Life Sciences Ltd.'s (NASDAQ:WVE) Earnings Trajectory?
finance.yahoo.com - April 23 at 4:29 PM
Wave Life Sciences Plunges After DMD Study Data ReadoutWave Life Sciences Plunges After DMD Study Data Readout
www.msn.com - April 17 at 12:43 PM
Qualcomm and Progressive jump while Wave Life Sciences dropsQualcomm and Progressive jump while Wave Life Sciences drops
marketbeat.com - April 16 at 5:30 PM
Why Wave Life Sciencess Valuation Is Falling By 25%Why Wave Life Sciences's Valuation Is Falling By 25%
www.benzinga.com - April 16 at 12:52 PM
Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial DesignWave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design
finance.yahoo.com - April 16 at 12:52 PM
Wave Life Sciences to Host Investor Conference Call to Discuss Suvodirsen DMD Clinical Data Being Presented at MDA Clinical and Scientific ConferenceWave Life Sciences to Host Investor Conference Call to Discuss Suvodirsen DMD Clinical Data Being Presented at MDA Clinical and Scientific Conference
finance.yahoo.com - April 12 at 12:54 PM
Wave Life Sciences Plunges on Clinical Trial Data DelayWave Life Sciences Plunges on Clinical Trial Data Delay
finance.yahoo.com - April 10 at 4:40 PM
Wave Life Sciences Provides Timing Update on PRECISION-HD Clinical ProgramsWave Life Sciences Provides Timing Update on PRECISION-HD Clinical Programs
finance.yahoo.com - April 10 at 10:23 AM
Sarepta plans second Duchenne drug application this yearSarepta plans second Duchenne drug application this year
finance.yahoo.com - March 28 at 12:11 PM
Wave Life Sciences to Present Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design at the Muscular Dystrophy Association Clinical and Scientific ConferenceWave Life Sciences to Present Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design at the Muscular Dystrophy Association Clinical and Scientific Conference
finance.yahoo.com - March 25 at 10:16 AM
WaVe Life Sciences LtdWaVe Life Sciences Ltd
www.bloomberg.com - March 18 at 4:29 PM
Should You Be Worried About Insider Transactions At Wave Life Sciences Ltd. (NASDAQ:WVE)?Should You Be Worried About Insider Transactions At Wave Life Sciences Ltd. (NASDAQ:WVE)?
finance.yahoo.com - March 7 at 4:29 PM
Wave Life Sciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Business UpdateWave Life Sciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Business Update
finance.yahoo.com - March 1 at 11:50 AM
Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical OfficerPioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer
finance.yahoo.com - February 12 at 4:16 PM
WAVE Life Sciences Ltd.WAVE Life Sciences Ltd.
www.barrons.com - February 12 at 11:27 AM
Why Wave Life Sciences Ltd.’s (NASDAQ:WVE) CEO Pay Matters To YouWhy Wave Life Sciences Ltd.’s (NASDAQ:WVE) CEO Pay Matters To You
finance.yahoo.com - January 29 at 4:18 PM
Wave Life Sciences down 4% on disclosure of FDA action on Huntingtons programsWave Life Sciences down 4% on disclosure of FDA action on Huntington's programs
seekingalpha.com - January 25 at 4:19 PM
Here's Why Wave Life Sciences Is Crashing TodayHere's Why Wave Life Sciences Is Crashing Today
finance.yahoo.com - January 24 at 4:25 PM
Wave Life Sciences prices stock offering at $38; shares down 10% premarketWave Life Sciences prices stock offering at $38; shares down 10% premarket
seekingalpha.com - January 24 at 11:15 AM
Wave Life Sciences Announces Proposed Public Offering of Ordinary SharesWave Life Sciences Announces Proposed Public Offering of Ordinary Shares
finance.yahoo.com - January 24 at 11:15 AM
Wave Life Sciences Prices $150 Million Public Offering of Ordinary SharesWave Life Sciences Prices $150 Million Public Offering of Ordinary Shares
finance.yahoo.com - January 24 at 11:15 AM
Here's Why Sarepta Therapeutics Fell 15.7% in DecemberHere's Why Sarepta Therapeutics Fell 15.7% in December
finance.yahoo.com - January 4 at 4:29 PM
Wave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot ProgramWave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot Program
globenewswire.com - January 3 at 10:08 AM
Wave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot ProgramWave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot Program
finance.yahoo.com - January 3 at 10:08 AM
How Financially Strong Is Wave Life Sciences Ltd. (NASDAQ:WVE)?How Financially Strong Is Wave Life Sciences Ltd. (NASDAQ:WVE)?
finance.yahoo.com - December 12 at 5:32 PM
Wave Life Sciences advancing DMD candidate WVE-210201Wave Life Sciences advancing DMD candidate WVE-210201
seekingalpha.com - December 6 at 4:18 PM
Wave Life Sciences Announces Positive Phase 1 Results for WVE-210201 in Duchenne Muscular Dystrophy (DMD)Wave Life Sciences Announces Positive Phase 1 Results for WVE-210201 in Duchenne Muscular Dystrophy (DMD)
finance.yahoo.com - December 6 at 9:40 AM
Wave Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business UpdateWave Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - November 9 at 10:03 AM
Wave Life Sciences: 3Q Earnings SnapshotWave Life Sciences: 3Q Earnings Snapshot
finance.yahoo.com - November 9 at 10:03 AM
Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue EstimatesWave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 9 at 10:03 AM
Wave Life Sciences to Present at the Jefferies 2018 London Healthcare ConferenceWave Life Sciences to Present at the Jefferies 2018 London Healthcare Conference
finance.yahoo.com - November 8 at 9:49 AM
Earnings Preview: Wave Life Sciences (WVE) Q3 Earnings Expected to DeclineEarnings Preview: Wave Life Sciences (WVE) Q3 Earnings Expected to Decline
www.zacks.com - November 1 at 4:16 PM
Should You Be Holding Wave Life Sciences Ltd (NASDAQ:WVE) Right Now?Should You Be Holding Wave Life Sciences Ltd (NASDAQ:WVE) Right Now?
finance.yahoo.com - October 9 at 4:07 PM
Wave Life Sciences to Develop Programs in Rare, Genetic Eye DiseasesWave Life Sciences to Develop Programs in Rare, Genetic Eye Diseases
finance.yahoo.com - October 9 at 9:11 AM
Wave Life Sciences Breaks Below 200-Day Moving Average - Notable for WVEWave Life Sciences Breaks Below 200-Day Moving Average - Notable for WVE
www.nasdaq.com - October 4 at 4:12 PM
Wave Life Sciences to Present New Data on Its DMD Exon 53 Skipping Program and Discovery Platform at Upcoming MeetingsWave Life Sciences to Present New Data on Its DMD Exon 53 Skipping Program and Discovery Platform at Upcoming Meetings
finance.yahoo.com - September 20 at 10:14 AM
Wave Life receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201Wave Life receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201
seekingalpha.com - August 16 at 9:42 AM
Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201
finance.yahoo.com - August 16 at 9:42 AM
Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue EstimatesWave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 9 at 4:15 PM
Wave Life Sciences up 5% premarket on Q2 resultsWave Life Sciences up 5% premarket on Q2 results
seekingalpha.com - August 9 at 9:50 AM
Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business UpdateWave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - August 9 at 9:50 AM
This page was last updated on 6/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel